Please login to the form below

Not currently logged in
Email:
Password:

TAK-003

This page shows the latest TAK-003 news and features for those working in and with pharma, biotech and healthcare.

Sanofi confirms suspected safety issue with dengue vaccine

Sanofi confirms suspected safety issue with dengue vaccine

The setbacks for Dengvaxia provide an opportunity for rival Takeda to leapfrog Sanofi with its own dengue vaccine candidate TAK-003, which has showed a higher rate of protective efficacy in ... Industry watchers have suggested TAK-003 could be on the

Latest news

  • Takeda dengue vaccine data looks good as it chases Sanofi Takeda dengue vaccine data looks good as it chases Sanofi

    Takeda dengue vaccine data looks good as it chases Sanofi. TAK-003 achieved a 71% reduction in developing the virus compared to placebo. ... The reduced incidence of dengue in children and adolescents receiving TAK-003 is encouraging, however data from

  • Takeda plans German plant to support dengue vaccine roll-out Takeda plans German plant to support dengue vaccine roll-out

    The plant in Singen is a "major step towards meeting important unmet needs in dengue prevention," according to the Japanese drugmaker, which recently started a phase III trial of its ... Takeda started its phase III TIDES trial of the live-attenuated

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics